MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
24h
Current
Min
16.17
Max
17.05
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +65.95% upside |
Past performance is not a reliable indicator of future results.
19 Dec 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 27 USD 65.95%
High 30 USD
Low 24 USD
Based on 4 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Strong Buy
4 ratings
3
Buy
1
Hold
0
Sell
Based on 4 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$